Close mobile menu×
Close mobile menu

Sabrina P. Law, MD

Board Certifications: 
Pediatric Cardiology, Pediatrics
Accepting New Patients
Treats Children
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 305-6575

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Pediatric Cardiology
  • Pediatrics

Clinical Expertise

  • Pediatric Cardiology
  • Pediatric Congenital Heart Disease
  • Pediatric Heart Failure
  • Cardiomyopathy
  • Heart Transplant, Pediatric
  • Ventricular Assist Device

Education & Training

  • MD, St Johns National Academy of Health Sciences, India
  • Residency: Westchester Medical Center - Maria Fareri Children's Hospital
  • Fellowship: Texas Children's Hospital
  • Fellowship: Steven and Alexandra Cohen Children's Medical Center

Honors & Awards

2009      Women in Cardiology, Trainee Award for Excellence, Sponsored by the American Heart Association. 

2007       Academic Excellence Award, Maria Fareri Children’s Hospital, Westchester Medical Center. Valhalla, NY        

About Sabrina Law

“Let the beauty we love be what we do. There are hundreds of ways to kneel and kiss the ground.” - Rumi 

Dr. Sabrina Law joined the Division of Pediatric Cardiology in 2014, and serves as the Medical Director of the Pediatric Ventricular Assist Device (VAD) Program. During her tenure, CHONY has used four times as many VADs as a bridge to transplantation or recovery. She is is an integral part of the Program for Pediatric Cardiomyopathy, Heart Failure and Transplantation. She specializes in caring for children with end stage heart failure secondary to congenital or acquired cardiomyopathies, failed palliated or non-palliated terminal congenital heart disease, and acquired cardiac disorders. Her clinical and research interests are focused upon evaluating the use of ventricular assist devices for children with acute decompensated heart failure. She is the Site Co- Principal Investigator in a national trial evaluating the use of newer ventricular assist devices in small children (Pumps in kids infants and neonates, PumpKIN). Following completion of an Advanced Fellowship in Pediatric Heart Failure Cardiomyopathy and Transplantation at Texas Children’s Hospital, Dr. Law previously worked at Seattle Children’s Hospital, where she helped build the Pediatric VAD program.

Academic Titles

  • Assistant Professor of Pediatrics at CUMC

Administrative Positions

  • Medical Director, Pediatric Ventricular Assist Device Program

Committee/Societies/Council Memberships

Lead of Pediatric VAD Steering Committee. The goal of the committee is to provide input on the strategic planning and coordination of the Pediatric VAD Program. The committee seeks input from each discipline (Heart Failure/ Transplant, Perfusion, ICU, Floor and ICU Nursing Leadership, Floor and ICU nurses, Hemetology as well as CT Surgery) to discuss how to best approach the different aspects of care for patients supported by VAD. Every discipline’s expertise is taken into consideration while incorporating policies, procedures and education. So far the committe has been instrumental in developing Institutional Anticoagulation Guidelines for ventricular assist devices in children, and instructional material and curriculum design used locally, as well as Quality Improvement Protocols for Transplant, Cardiomyopathy and Ventricular Assist Device Program

Site PI and Co-investigator for Safety and Benefit of a Novel Anticoagulation Protocol for Berlin EXCOR. Prospective multicenter study to evaluate the adherence, safety and efficacy of a novel anticoagulation protocol for children supported on the Berlin Heart EXCOR. US Food and Drug Administration, Orphan products grant.

Cardiology Co-Principal Investigator for PUMPKIN Trial Clinical Site, New York Presbyterian Morgan Stanley Children’s Hospital, New York, NY. The PUMPKIN trial is a randomized, multicenter, trial evaluating the investigational Infant Jarvik 2000 Heart System versus the EXCOR Pediatric device in Pediatric patients with heart failure.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Access (Exchange)
  • EPO
  • Gatekeeper (Exchange)
  • HMO
  • Medicare Managed Care
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
3959 Broadway
Suite BHN 2-255
New York, New York 10032
Phone:
(212) 305-6575
Primary

Research

Selected Publications

  1. Wittlieb-Weber CA, Villa CR, Conway J, Bock MJ, Gambetta KE, Johnson JN, Lal AK, Schumacher KR, Law SP, Deshpande SR, West SC, Friedland-Little JM, Lytrivi ID, McCulloch MA, Butts RJ, Weber DR, Knecht KR. Use of Advanced Heart Failure Therapies in Duchenne Muscular Dystrophy. Prog Pediatr Cardiol. Accepted for publication: January, 2019.
  2. Influenza Myocarditis Treated with Antithymocyte Globulin. Piccininni JA, Richmond ME, Cheung E2, Lee TM, Law SP, Addonizio LJ, Zuckerman WA. Pediatrics. 2018 Nov;142(5). pii: e20180884. doi: 10.1542/peds.2018-0884. Epub 2018 Oct 23.
  3. Changes in renal function after left ventricular assist device placement in pediatric patients: A Pedimacs analysis. Friedland-Little JM, Hong BJ, Gossett JG, Deshpande SR, Law S, Hollifield KA, Cantor RS, Koehl D, Kindel SJ, Turrentine MW, Davies RR. J Heart Lung Transplant. 2018 Oct;37(10):1218-1225. doi: 10.1016/j.healun.2018.06.016. Epub 2018 Jul 24. PMID: 30293616
  4. Comparison of Transplant Waitlist Outcomes for Pediatric Candidates Supported by Ventricular Assist Devices Versus Medical Therapy. Law SP, Oron AP, Kemna MS, Albers EL, McMullan DM, Chen JM, Law YM. Pediatr Crit Care Med. 2018 May;19(5):442-450.
  5. Post-transplant outcomes in pediatric ventricular assist device patients: A PediMACS-Pediatric Heart Transplant Study linkage analysis. Sutcliffe DL, Pruitt E, Cantor RS, Godown J, Lane J, Turrentine MW, Law SP, Lantz JL, Kirklin JK, Bernstein D, Blume ED. J Heart Lung Transplant. 2018 Jun;37(6):715-722. doi: 10.1016/j.healun.2017.12.004. Epub 2017 Dec 13
  6. Delineating Survival Outcomes in Children less than 10 Kg bridged to Transplant or Recovery with the Berlin heart EXCOR Pediatric Ventricular Assist Device. Conway J, St Louis J, Morales D, Law S, Tjossem C, Humpl T.  JACC Heart Fail. 2015 Jan;3(1):70-7
  7. HLA Molecular Epitope Mismatching and Long Term Graft Loss in Pediatric Heart Recipients. Paul Warner, PhD; Mariska S Kemna, MD; Erin L Albers, MD, MSCI; Sabrina P Law, MD; Noel S Weiss, MD, DrPH; Yuk M Law, MD. J Heart Lung Transplant. 2015 Jul;34(7):950-7. doi: 10.1016/j.healun.2014.12.017. Epub 2014 Dec 24
  8. Impact of Donor-Recipient Sex-Match on Long Term Survival after Heart Transplantation in Children: An Analysis of 5797 Pediatric Heart Transplants. Mariska Kemna, Erin Albers, MD; Miranda C Bradford, MS; Sabrina Law, MD; Lester Permut, MD; D. Mike McMullan, MD; Yuk Law, MD. An analysis of 5797 Heart Transplants. Pediatr Transplant. 2015 Dec 22. doi: 10.1111/petr.12649.
  9. Eosinophil Count, Allergies, and Rejection in Pediatric Heart Transplant Recipients. Arbon, K., Albers, E., Kemna, M., Law, S., Law, Y. 2015 Aug;34(8):1103-11. doi: 10.1016/j.healun.2015.03.014. Epub 2015 Mar 27
  10. Dose Conversion Factor between Cyclosporine and Tacrolimus in Pediatric Heart Transplant Recipients. Eliza Notaro, Lisa Brown, Erin Albers, Sabrina Law, Mariska Kemna. J Heart Lung Transplant. 2014 Jul;33(7):766-8.
  11. Diffuse Rhabdomyomatosis Presenting as Infantile Hypertrophic Cardiomyopathy. Sabrina Law, Terrence Chun, Raj Kapur. J Heart Lung Transplant. 2014 Apr;33(4):452-4.
  12. Hospital Charges for Pediatric Heart Transplant Hospitalizations in the United States from 1997 to 2006. Sabrina P. Law, MD, Jeffrey J. Kim, MD, Jamie A. Decker, MD, Jack F. Price, MD, Antonio G. Cabrera, MD, Daniel E. Graves, PhD, David L. S. Morales, MD, Jeffrey S. Heinle, MD, Susan W. Denfield, MD, William J. Dreyer, MD, and Joseph W. Rossano, MD. J Heart Lung Transplant 2012;31:485–91
  13. A newborn with cardiomegaly. Upadhyay S, Law S, Kholwadwalla D. J Emerg Trauma Shock. 2010 Jul;3(3):298. doi: 10.4103/0974-2700.66541.